Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 61801-61850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04161053
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
PHASE3Recruiting
60 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03729752
PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
PHASE1Recruiting
30 participants
Started: Nov 1, 2018 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT03711773
Outcomes of Low-Impact Exercise Program for People with Ankle, Knee, And/or Hip Pain
NARecruiting
10,000 participants
Started: Nov 1, 2018 · Completed: Jan 1, 2030
4 conditions1 sponsor1 location
NCT04216186
Role of Coenzyme Q in ADHD in Children
PHASE3Recruiting
40 participants
Started: Nov 1, 2018 · Completed: Dec 1, 2030
1 condition1 sponsor1 location
NCT05838079
Copenhagen Baby Heart Study - Impact
N/ARecruiting
35,000 participants
Started: Nov 1, 2018 · Completed: Jul 31, 2029
1 condition3 sponsors3 locations
NCT03752775
Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke
NARecruiting
45 participants
Started: Nov 1, 2018 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03661307
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
73 participants
Started: Oct 31, 2018 · Completed: Jan 1, 2026
5 conditions3 sponsors1 location
NCT03689595
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
N/ARecruiting
30,000 participants
Started: Oct 31, 2018 · Completed: Oct 31, 2033
1 condition1 sponsor1 location
NCT04794777
"Comparing Salvage Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer"
PHASE3Recruiting
450 participants
Started: Oct 30, 2018 · Completed: Oct 30, 2027
1 condition1 sponsor5 locations
NCT03827694
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
N/ARecruiting
400 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2026
2 conditions3 sponsors33 locations
NCT06381271
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
N/ARecruiting
500 participants
Started: Oct 30, 2018 · Completed: Oct 31, 2034
1 condition1 sponsor1 location
NCT04331392
Online Memory Intervention for Individuals with Traumatic Brain Injury
NARecruiting
84 participants
Started: Oct 30, 2018 · Completed: Feb 28, 2027
4 conditions3 sponsors1 location
NCT04050644
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
PHASE4Recruiting
100 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2024
1 condition2 sponsors2 locations
NCT03858231
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
PHASE4Recruiting
148 participants
Started: Oct 29, 2018 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT03794362
Measuring Analgesic Interventions
N/ARecruiting
120 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03629171
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
PHASE2Recruiting
52 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03744819
Biomarkers for Prediction of Tumor Response to Radiotherapy
N/ARecruiting
100 participants
Started: Oct 29, 2018 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05918666
National Register of Actionable Mutations
N/ARecruiting
3,000 participants
Started: Oct 27, 2018 · Completed: Oct 27, 2026
1 condition12 sponsors42 locations
NCT03631420
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
PHASE1Recruiting
9 participants
Started: Oct 26, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT03664869
Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer
PHASE3Recruiting
300 participants
Started: Oct 26, 2018 · Completed: Nov 1, 2025
1 condition2 sponsors7 locations
NCT03897270
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
NARecruiting
400 participants
Started: Oct 25, 2018 · Completed: Oct 25, 2025
2 conditions2 sponsors1 location
NCT03721744
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
PHASE2/PHASE3Recruiting
336 participants
Started: Oct 25, 2018 · Completed: Sep 30, 2025
1 condition1 sponsor38 locations
NCT03943745
EEG Changes During Induction of Propofol Anesthesia
N/ARecruiting
50 participants
Started: Oct 25, 2018 · Completed: May 31, 2024
2 conditions3 sponsors1 location
NCT03564197
18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC
NARecruiting
80 participants
Started: Oct 25, 2018 · Completed: Dec 30, 2024
1 condition2 sponsors8 locations
NCT03586609
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
PHASE2Recruiting
145 participants
Started: Oct 25, 2018 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04173442
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
N/ARecruiting
500 participants
Started: Oct 24, 2018 · Completed: Jan 30, 2026
2 conditions2 sponsors1 location
NCT03588975
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
PHASE3Recruiting
45 participants
Started: Oct 24, 2018 · Completed: Jun 30, 2027
4 conditions1 sponsor12 locations
NCT03536793
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
N/ARecruiting
180 participants
Started: Oct 24, 2018 · Completed: Feb 28, 2029
2 conditions2 sponsors1 location
NCT03714490
MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer
PHASE2Recruiting
200 participants
Started: Oct 23, 2018 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT03710109
Evaluation of an EEG Based Concussion System
N/ARecruiting
150 participants
Started: Oct 23, 2018 · Completed: Dec 3, 2025
1 condition1 sponsor2 locations
NCT03663504
Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery
PHASE4Recruiting
630 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT03665831
Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults
NARecruiting
28 participants
Started: Oct 23, 2018 · Completed: Sep 15, 2026
3 conditions3 sponsors1 location
NCT03721822
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
PHASE1Recruiting
100 participants
Started: Oct 23, 2018 · Completed: Oct 23, 2026
3 conditions1 sponsor1 location
NCT03704662
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
NARecruiting
102 participants
Started: Oct 22, 2018 · Completed: Jun 1, 2031
1 condition1 sponsor1 location
NCT03539822
Cabozantinib Plus Durvalumab with or Without Tremelimumab in Patients with Gastroesophageal Cancer and Other Gastrointestinal Malignancies
PHASE1/PHASE2Recruiting
117 participants
Started: Oct 22, 2018 · Completed: Jan 31, 2028
4 conditions3 sponsors2 locations
NCT03580785
Primary Failure of Eruption (PFE) : Highlighting of Clinical, Radiological and Genetic Diagnostic Criteria: Consequences on the Therapeutic Management
NARecruiting
50 participants
Started: Oct 22, 2018 · Completed: Oct 12, 2025
1 condition1 sponsor1 location
NCT03428828
Neurofeedback for Treatment Resistant Depression
NARecruiting
100 participants
Started: Oct 22, 2018 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT03180320
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
NARecruiting
150 participants
Started: Oct 22, 2018 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT03587064
Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
NARecruiting
640 participants
Started: Oct 22, 2018 · Completed: Apr 30, 2025
2 conditions1 sponsor24 locations
NCT03717441
DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles
N/ARecruiting
250 participants
Started: Oct 22, 2018 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT03619551
Conditioning SCID Infants Diagnosed Early
PHASE2Recruiting
56 participants
Started: Oct 22, 2018 · Completed: Aug 1, 2030
1 condition1 sponsor52 locations
NCT03781648
Water Exchange With Narrow Band Imaging on Adenoma Detection
NARecruiting
360 participants
Started: Oct 20, 2018 · Completed: Oct 20, 2024
1 condition1 sponsor1 location
NCT03641898
Intravascular Ultrasound-derived Assessment of Hemodynamically Negative Lesions in NSTEACS Patients
N/ARecruiting
350 participants
Started: Oct 20, 2018 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03474978
Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates
NARecruiting
320 participants
Started: Oct 19, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03729765
Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients
NARecruiting
60 participants
Started: Oct 19, 2018 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT03711539
Lifetime Endurance Exercise to Prevent Coronary Artery Disease
N/ARecruiting
1,800 participants
Started: Oct 18, 2018 · Completed: Oct 1, 2025
3 conditions3 sponsors3 locations
NCT03732131
The Finnish Faecal Microbiota Transplantation Study (FINFMT)
N/ARecruiting
200 participants
Started: Oct 18, 2018 · Completed: Jan 15, 2029
1 condition19 sponsors1 location
NCT04344496
East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction
N/ARecruiting
2,000 participants
Started: Oct 18, 2018 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT03709758
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
PHASE1Recruiting
64 participants
Started: Oct 17, 2018 · Completed: Jun 1, 2026
1 condition3 sponsors2 locations
NCT03710902
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
NARecruiting
405 participants
Started: Oct 17, 2018 · Completed: Sep 30, 2028
5 conditions1 sponsor4 locations